Tharimmune, Inc. | WebDisclosure

Basculer en Français

9479	Companies
185504	Keywords
117879	Articles
99354	Press releases

Home
Companies
Tharimmune, Inc.

BRIEF

published on 04/28/2025 at 14:06, 7 months 7 days ago

Le TH104 de Tharimmune se rapproche de la lutte contre la menace du fentanyl militarisé

TH104 Tharimmune Commentaires De La FDA Sécurité Nationale Opioïdes À Haute Puissance
BRIEF

published on 04/28/2025 at 14:06, 7 months 7 days ago

Tharimmune's TH104 Moves Closer to Addressing Weaponized Fentanyl Threat

National Security TH104 FDA Feedback Tharimmune High-Potency Opioids
PRESS RELEASE

published on 04/28/2025 at 14:01, 7 months 7 days ago

Tharimmune Advances TH104 for Prophylaxis Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
Tharimmune, Inc. receives positive FDA feedback on TH104, a buccal film formulation of nalmefene for prophylaxis of opioid exposure in military personnel & first responders

TH104 Buccal Film FDA Feedback Tharimmune Opioid Exposure
BRIEF

published on 04/15/2025 at 15:05, 7 months 20 days ago

Tharimmune renforce son conseil d'administration avec la nomination de Vincent LoPriore

Biotechnologie Stratégie Financière Nomination Au Conseil D'administration Tharimmune Vincent LoPriore
BRIEF

published on 04/15/2025 at 15:05, 7 months 20 days ago

Tharimmune Enhances Board with Vincent LoPriore Appointment

Biotechnology Board Appointment Financial Strategy Tharimmune Vincent LoPriore
PRESS RELEASE

published on 04/15/2025 at 15:00, 7 months 20 days ago

Tharimmune Strengthens Strategic Leadership with the Appointment of Vincent LoPriore to its Board of Directors
Tharimmune, Inc. appoints Vincent LoPriore to its Board of Directors to bolster strategic leadership and drive growth in immunology and oncology. The move reflects the company's commitment to enhancing its leadership team with experienced financial professionals

Board Of Directors Oncology Tharimmune, Inc. Immunology Vincent LoPriore
BRIEF

published on 04/07/2025 at 14:05, 7 months 28 days ago

Tharimmune dévoile des données prometteuses sur de nouveaux traitements biologiques

Traitement Du Cancer Produits Biologiques Tharimmune Technologie EpiClick HS1940 HS3215
BRIEF

published on 04/07/2025 at 14:05, 7 months 28 days ago

Tharimmune Unveils Promising Data on New Biologic Treatments

Cancer Treatment Tharimmune Biologics EpiClick Technology HS1940 HS3215
PRESS RELEASE

published on 04/07/2025 at 14:00, 7 months 28 days ago

Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology
Tharimmune, Inc. announces preclinical data on novel dual-target biologics HS1940 and HS3215 using EpiClick™ Technology to address cancer treatment needs

Cancer Treatment Tharimmune Inc. Preclinical Data EpiClick Technology Dual-target Biologics
BRIEF

published on 03/31/2025 at 14:05, 8 months 5 days ago

Tharimmune reçoit l'approbation de la FDA pour la voie TH104 NDA

TH104 Tharimmune Commentaires De La FDA Parcours 505(b)(2) Prophylaxie Aux Opioïdes

Accesswire

Published on 12/05/2025 at 17:15, 15 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 30 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 30 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 45 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 45 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:00, 30 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 5 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 20 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 30 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 30 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 17:18, 12 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 12 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 19 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 19 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 32 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE